Start for free
Start for free
DI

Dansk Innovation

Description

Dansk Innovation is a venture capital firm specialized in early stage investments.

Investor Profile

Dansk Innovation has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (44%)
  • Series B (33%)
  • Series D (11%)
  • Series C (11%)

Country Focus

  • Switzerland (56%)
  • Denmark (44%)

Industry Focus

  • Biotechnology
  • Health Care
  • Food And Beverage
  • Wellness
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dansk Innovation frequently co-invest with?

Wellington Partners
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 2
BioMedPartners
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
YV
Yamanouchi Venture Capital
North America, California, United States, Palo Alto
Co-Investments: 3
Aravis Ventures
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4
Index Ventures
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 4
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 4
VINCI CAPITAL
VINCI CAPITAL
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 2
Auriga Partners
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by Dansk Innovation?

Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BDec 11, 2009
Amount Raised: $15,518,703
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BOct 22, 2009
Amount Raised: $27,828,853
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series DJun 12, 2007
Amount Raised: $22,000,000
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series ADec 1, 2006
Amount Raised: $10,300,000
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series CMar 31, 2006
Amount Raised: $23,029,661
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series AMar 21, 2005
Amount Raised: $2,635,081
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series BOct 28, 2004
Amount Raised: $7,645,221
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series AAug 16, 2004
Amount Raised: $14,813,553
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series ASep 27, 2001
Amount Raised: $15,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator